https://www.marketwatch.com/investing/secfile/15823171
Nine months ended March 31, 2022 During the nine months ended March31, 2022, the Company issued 381,457,044 shares of common stock upon conversion of convertible notes in the amount of $255,900 of principal,plus accrued interest of $106,484 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of theirrespective agreements and therefore no gain or loss on the conversion was recorded.
During the nine months ended March31, 2022, the Company issued 40,983,607 shares of common stock pursuant to a purchase agreement for cash at a price of $0.02745 per sharefor aggregate net proceeds of $960,000.
Management evaluated subsequent eventsas of the date of the financial statements pursuant to ASC TOPIC 855, and there were no subsequent events to report.
|